Renflexis (infliximab)

pCPA File Number: 21027
Negotiation Status:
Concluded with an LOI
Indication(s):
Rheumatic Conditions
Sponsor/Manufacturer:
Merck Canada Inc.
CADTH Project Number:
SE0532-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: